Dr Anil Kumar Chowdhary – Trademark Portfolio

Entity Type: 01

Dr Anil Kumar Chowdhary holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include QUIKEVAL and ALIGNERAI. The owner is based in Fremont, CA.

3200 Mowry Drive Suite A,

Fremont, CA 94538

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Dr Anil Kumar Chowdhary's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Dr Anil Kumar Chowdhary have?

Dr Anil Kumar Chowdhary has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Dr Anil Kumar Chowdhary file in?

Dr Anil Kumar Chowdhary files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Dr Anil Kumar Chowdhary's most well-known trademarks?

Dr Anil Kumar Chowdhary's registered trademark portfolio includes well-known marks such as QUIKEVAL and ALIGNERAI. These are among 2 currently registered trademarks in the portfolio.

What is Dr Anil Kumar Chowdhary's trademark registration success rate?

Dr Anil Kumar Chowdhary has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.